Emox 911 CC

Emox 911 CC produces two main categories of medical devices: emergency oxygen therapy systems and burn care products. Their EMOX device is a portable system for rapid oxygen delivery in critical situations, while their BURN-AID line includes HYDROGEL (a topical burn treatment), BURN DRESSING, and BURN BLANKET (for wound coverage and thermal protection). These products address both acute respiratory support and wound management.

Emox 911 CC is based in the United States, which means its devices are subject to FDA oversight. The company’s products are listed in the FDA’s 510(k) registry, indicating they have undergone the required premarket submission process to demonstrate substantial equivalence to legally marketed predicate devices. This pathway is common for Class II and Unclassified (Class U) devices in the US.

Emox 911 CC’s devices fall into two regulatory classifications: Class II and Unclassified (Class U). Class II devices typically require special controls beyond general controls to ensure safety and effectiveness, while Unclassified devices are those not yet assigned a risk class but still require regulatory oversight. The classification determines the level of scrutiny during submission (e.g., 510(k) for Class II) and post-market requirements.

Emox 911 CC’s devices are listed in the FDA’s 510(k) registry, a public database of premarket notifications for Class II and some Class III devices. This registry reflects that the company’s products have undergone the 510(k) pathway, where manufacturers demonstrate their device is substantially equivalent to a legally marketed predicate. Listing here confirms compliance with US regulatory requirements for authorised devices.